Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status. [electronic resource]
Producer: 20060901Description: 309-14 p. digitalISSN:- 0306-5251
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Administration, Oral
- Adult
- Area Under Curve
- Aryl Hydrocarbon Hydroxylases -- genetics
- Benzimidazoles -- blood
- Cross-Over Studies
- Cytochrome P-450 CYP2C19
- Double-Blind Method
- Enzyme Inhibitors -- blood
- Female
- Fluvoxamine -- administration & dosage
- Heterozygote
- Homozygote
- Humans
- Male
- Mixed Function Oxygenases -- genetics
- Omeprazole -- analogs & derivatives
- Rabeprazole
- Selective Serotonin Reuptake Inhibitors -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.